Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Gynecological”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Not applicableStudy completedNCT04141618
What this trial is testing

The Role of NLRP Gene Family (NLRP1~14) in Recurrent Miscarriage and Infertility

Who this might be right for
Miscarriage, RecurrentInfertility
National Cheng-Kung University Hospital 143
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738757
What this trial is testing

SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies

Who this might be right for
Recurrent or Metastatic MSI-H/dMMR Gynecological Malignancies
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT05990803
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies

Who this might be right for
Cervical Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)UnknownNCT03827837
What this trial is testing

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more
Jiangsu HengRui Medicine Co., Ltd. 265
Testing effectiveness (Phase 2)Looking for participantsNCT06798207
What this trial is testing

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Who this might be right for
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT04395079
What this trial is testing

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Who this might be right for
Metastatic Malignant Female Reproductive System NeoplasmPlatinum-Resistant Malignant Female Reproductive System NeoplasmRecurrent Malignant Female Reproductive System Neoplasm+1 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05028504
What this trial is testing

A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer

Who this might be right for
Gynecological Cancer
Sichuan Cancer Hospital and Research Institute 86
Not applicableUnknownNCT05612620
What this trial is testing

Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss

Who this might be right for
MicrobiomeRecurrent Pregnancy Loss
Assuta Ashdod Hospital 40
Post-approval studies (Phase 4)UnknownNCT04035785
What this trial is testing

A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)

Who this might be right for
Pelvic Inflammatory Diseases
China Academy of Chinese Medical Sciences 240
Testing effectiveness (Phase 2)Looking for participantsNCT06131450
What this trial is testing

BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

Who this might be right for
Gynecological Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 138
Not applicableLooking for participantsNCT04957511
What this trial is testing

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Who this might be right for
Gynecologic CancerImmunotherapyGut Microbiome
Viome 30
Testing effectiveness (Phase 2)Ended earlyNCT01184053
What this trial is testing

Trisenox® in Women With Metastatic Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center 3
Not applicableLooking for participantsNCT05457595
What this trial is testing

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

Who this might be right for
Tumor RecurrenceMalignant Epithelial Neoplasm of VulvaMalignant Epithelial Tumor of Ovary+1 more
CNAO National Center of Oncological Hadrontherapy 55
Testing effectiveness (Phase 2)UnknownNCT04699071
What this trial is testing

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Who this might be right for
AdenocarcinomasRecurrent Gynecological
National University Hospital, Singapore 10
Early research (Phase 1)Study completedNCT00268918
What this trial is testing

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+3 more
Dana-Farber Cancer Institute 24
Not applicableNot Yet RecruitingNCT07267780
What this trial is testing

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

Who this might be right for
Ovarian CarcinomaCervical CarcinomaEndometrial Carcinoma+3 more
National Cancer Institute, Naples 130
Next Page
9